AP-2β was also a helpful diagnostic marker for discrimination between embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma upon diagnosing a child with rhabdomyosarcoma and a predictor prognosis marker for unfavorable overall survival [32–34]. This evidence concerns the gene TFAP2B and embryonal rhabdomyosarcoma.